INS 101
Alternative Names: Gene therapies - InnoSkel; INS-101Latest Information Update: 20 Dec 2021
At a glance
- Originator Institut de Biologie Valrose
- Developer InnoSkel
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Connective tissue disorders; Spondyloepiphyseal dysplasia congenita